Long-term efficacy of opicapone in the reduction of on-time with troublesome dyskinesia in Parkinson's disease patients with motor fluctuations and reporting troublesome dyskinesia

被引:0
|
作者
Stocchi, Fabrizio [1 ]
Ferreira, Joaquim [2 ]
Klepitskaya, Olga [3 ]
Magalhaes, Diogo [4 ]
Rocha, Jose [4 ]
Soares-Da-Silva, Patricio [4 ]
机构
[1] IRCCS San Raffaele Pisana, Dept Neurol, Rome, Italy
[2] Univ Lisbon, Fac Med, Lab Clin Pharmacol & Therapeut, Lisbon, Portugal
[3] Neurocrine Biosci Inc, Neurol Dept, San Diego, CA USA
[4] BIAL Portela & Ca SA, Global Parkinsons Dis Dept, Coronado, Portugal
关键词
D O I
10.1016/j.jns.2021.119442
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
119442
引用
收藏
页码:278 / 278
页数:1
相关论文
共 50 条
  • [31] 24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson’s disease
    Belinda Cruse
    Hugo Morales-Briceño
    Florence C F Chang
    Neil Mahant
    Ainhi D Ha
    Samuel D Kim
    Nigel Wolfe
    Vu Kwan
    David S Tsui
    Jane M Griffith
    Donna Galea
    Victor S C Fung
    [J]. npj Parkinson's Disease, 4
  • [32] Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinson's Disease
    Cenci, M. A.
    Ohlin, K. E.
    Odin, P.
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2011, 10 (06) : 670 - 684
  • [33] Evaluating the efficacy and safety of opicapone in patients over 70 years with Parkinson's disease and motor fluctuations
    Lees, A.
    Ferreira, J.
    Lopes, N.
    Costa, R.
    Santos, A.
    Oliveira, C.
    Pinto, R.
    Nunes, T.
    Rocha, J. F.
    Soares-da-silva, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 438 - 438
  • [34] 24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson's disease
    Cruse, Belinda
    Morales-Briceno, Hugo
    Chang, Florence C. F.
    Mahant, Neil
    Ha, Ainhi D.
    Kim, Samuel D.
    Wolfe, Nigel
    Kwan, Vu
    Tsui, David S.
    Griffith, Jane M.
    Galea, Donna
    Fung, Victor S. C.
    [J]. NPJ PARKINSONS DISEASE, 2018, 4
  • [35] Pooled efficacy analysis of opicapone as adjunctive therapy to levodopa in patients with Parkinson's disease and motor fluctuations
    Ferreira, J.
    Lees, A.
    Santos, A.
    Lopes, N.
    Costa, R.
    Oliveira, C.
    Pinto, R.
    Nunes, T.
    Rocha, J. F.
    Soares-da-silva, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 144 - 144
  • [36] Efficacy of opicapone according to different levodopa daily intakes in Parkinson's disease patients with motor fluctuations
    Ebersbach, G.
    Poewe, W.
    Ferreira, J.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    [J]. MOVEMENT DISORDERS, 2021, 36 : S169 - S170
  • [37] Adenosine A2A receptor antagonist istradefylline can be more beneficial in Parkinson's disease patients of advanced stage without troublesome dyskinesia
    Saiki, H.
    Matsumoto, S.
    [J]. MOVEMENT DISORDERS, 2015, 30 : S118 - S118
  • [39] Efficacy of opicapone according to different levodopa daily intakes in Parkinson's disease patients with motor fluctuations
    Ebersbach, Georg
    Poewe, Werner
    Ferreira, Joaquim
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 280 - 280
  • [40] Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia
    Fabbri, Margherita
    Zibetti, Maurizio
    Calandra-Buonaura, Giovanna
    Contin, Manuela
    Sambati, Luisa
    Mohamed, Susan
    Romagnolo, Alberto
    Berchialla, Paola
    Imbalzano, Gabriele
    Giannini, Giulia
    Rizzone, Mario G.
    Artusi, Carlo Alberto
    Cortelli, Pietro
    Lopiano, Leonardo
    [J]. MOVEMENT DISORDERS CLINICAL PRACTICE, 2020, 7 (08): : 930 - 939